Welcome to our dedicated page for MARKEL GROUP SEC filings (Ticker: MKL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Markel Group Inc. filings document the financial reporting, governance, and capital-structure disclosures of a diversified holding company centered on specialty insurance. Its regulatory record includes 8-K reports for annual and quarterly results, Regulation FD materials such as shareholder letters, leadership and compensation changes, and reporting changes tied to business re-segmentation.
Proxy filings describe board matters, executive compensation, shareholder voting items, and equity-award disclosures. Other filings address registered securities and plan-interest matters, including Costa Farms LLC 401(k) Plan disclosures, while preserving Markel Group’s continuing reporting obligations for its common shares.
Meade P. Grandis, Chief Accounting Officer and Controller of Markel Group Inc. (MKL), reported a sale on 08/25/2025 of 75 shares of Markel common stock for $1,983.78 as shown on this Form 4. The filing lists multiple categories of beneficial ownership across trusts, retirement plan and family members, including entries labeled "By Trusts," a 401(k) plan balance, an irrevocable trust, and holdings attributed to spouse, daughter and son. Explanatory footnotes describe the spouse’s role as co-trustee and a distribution of 3,569.5 shares from the trusts to the spouse; plan share details reflect the 401(k) balance as of June 30, 2025. The form is signed by an attorney-in-fact on behalf of the reporting person.